ELIXIR.LU news


Smart4Health project leaders meet at Belval

On May 15-16, Smart4Health leaders met to exchange on the latest progress and work plans in this ambitious new international EU project. As one of three Luxembourg partners, E...

IMI2: FAIRPlus grant awarded

ELIXIR-LU is a partner in the FAIRplus consortium, coordinated by the ELIXIR Hub, which will support EFPIA companies (European Federation of Pharmaceutical Industries and Associations) and specific IMI projects in ...

Luxinnovation celebrates the 10 years of IMI

On the occasion of the tenth anniversary of the Innovative Medicines Initiative (IMI), Luxinnovation interviewed Prof Dr Reinhard Schneider, Head of ELIXIR-LU. The interview focused on the involvement of ELIXIR-LU ...

Article about GDPR and biomedical research

Dr Regina Becker, in charge of strategy development for ELIXIR-LU, recently wrote an article regarding GDPR and its impact on biomedical research. Entitled “Biomedical research: achieving transparency under the Gen...

First national stakeholders meeting for ELIXIR-LU

On June 13, the ELIXIR-LU team invited several Luxembourgish stakeholders to a first meeting to introduce ELIXIR, the European infrastructure for life science information, and the national Node ELIXIR-LU, present r...

First Scientific Advisory Board meeting for ELIXIR-LU

On May 3, ELIXIR-LU held the first meeting of its Scientific Advisory Board (SAB), composed of five members heading various European research infrastructures and other ELIXIR Nodes (see list below).

In this...

More than 120 participants for a webinar about the GDPR

In February, Regina Becker, in charge of strategy development at ELIXIR Luxembourg, gave an introduction into the upcoming General Data Protection Legislation (GDPR) that will come into force on 25 May 2018.

<...